ONC201 and imipridones: Anti-cancer compounds with clinical efficacy
2020 · Neoplasia · 162 citations
https://doi.org/10.1016/j.neo.2020.09.005
R
Rohinton S. Tarapore
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
267
Papers
2.5K
Citations
29
h-index
36
i10-index
Rohinton S. Tarapore is an academic researcher from Jazz Pharmaceuticals (United States). The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & ATP Synthase and ATPases Research. The author has an h-index of 29, co-authored 227 publications.
ORCID: 0000-0002-8070-5646Papers by this author
worksPhase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
2022 · Neuro-Oncology Advances · 56 citations
https://doi.org/10.1093/noajnl/vdac143
Restoring KLF5 in Esophageal Squamous Cell Cancer Cells Activates the JNK Pathway Leading to Apoptosis and Reduced Cell Survival
2013 · Neoplasia · 48 citations
https://doi.org/10.1593/neo.122126
Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells
2021 · Scientific Reports · 16 citations
https://doi.org/10.1038/s41598-021-83215-y
Table S16 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026252.v1
Table S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026249
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat